These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 733863)

  • 1. Immunological and cytogenetic characterization of lymphocitic mouse leukemias after treatment with antineoplastic drugs.
    Conti AM; Marelli O; Nicolin A
    Pharmacol Res Commun; 1978 Nov; 10(10):867-84. PubMed ID: 733863
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of concanavalin A-bound L1210 vaccine in vivo by chemotherapeutic agents.
    Kataoka T; Kobayashi H; Sakurai Y
    Cancer Res; 1978 May; 38(5):1202-7. PubMed ID: 639053
    [No Abstract]   [Full Text] [Related]  

  • 3. "In vitro" induction of primary cell-mediated immune response to drug-altered lymphoma cells.
    Romani L; Fioretti MC
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1943-9. PubMed ID: 753282
    [No Abstract]   [Full Text] [Related]  

  • 4. Con A agglutination of DTIC-altered lymphoma cells.
    Nicolotti G; Gelfi P; Marelli O; Nicolin A
    Pharmacol Res Commun; 1978 Apr; 10(4):313-24. PubMed ID: 684037
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of ATP on cell agglutination of experimental tumors (author's transl)].
    Wang ZW; Chou PQ
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):245-8. PubMed ID: 6462024
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.
    Hancock EJ; Kilburn DG
    Cancer Immunol Immunother; 1982; 14(1):54-8. PubMed ID: 6819082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity induced in vivo by DIC in relatively non-immunogenic leukemias.
    Nicolin A; Cavalli M; Missiroli A; Goldin A
    Eur J Cancer (1965); 1977 Mar; 13(3):235-9. PubMed ID: 862643
    [No Abstract]   [Full Text] [Related]  

  • 8. Murine leukemia growth inhibition or enhancement following immunization with tumor cells antigenically altered by drug treatment.
    Riccardi C; Giampietri A; Puccetti P; Biancifiori F; Fioretti MC
    Pharmacol Res Commun; 1977 Apr; 9(4):349-58. PubMed ID: 141049
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of friend virus leukemogenesis by concanavalin A. I. Detection of dormant virus and role of humoral antibody in protected mice.
    Kateley JR; Friedman H
    J Natl Cancer Inst; 1974 Jul; 53(1):151-8. PubMed ID: 4835102
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug sensitivity tests after cell separation on density gradients.
    Silvestro L; Viano I; Compagnoni G; Soffiantino ML; Vercellone C; Genazzani E
    Anticancer Res; 1988; 8(1):119-23. PubMed ID: 3358627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia in AKR mice. II. Two modes of suppression of in vitro antibody formation by leukemic cells.
    Roman JM; Golub ES
    Cell Immunol; 1978 Oct; 40(2):316-25. PubMed ID: 719762
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of antineoplastic agents on the induction of suppressor macrophages by concanavalin A-bound tumor vaccine.
    Kataoka T; Oh-Hashi F; Sakurai Y; Ogihara K
    Cancer Res; 1981 Dec; 41(12 Pt 1):5151-7. PubMed ID: 6458357
    [No Abstract]   [Full Text] [Related]  

  • 14. Hybrid cells derived from fusion of TA2-Ha ascites carcinoma with normal fibroblasts. II. Characterization of isoantigenic variant sublines.
    Friberg S; Klein G; Wiener F; Harris H
    J Natl Cancer Inst; 1973 May; 50(5):1269-86. PubMed ID: 4712591
    [No Abstract]   [Full Text] [Related]  

  • 15. Strain differences in the proliferative response of murine spleen cells to mitogen.
    Malavé I
    Int Arch Allergy Appl Immunol; 1981; 64(1):1-10. PubMed ID: 7450898
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the pretreatment with some cytostatic agents on the growth rate of leukaemia L5178Y.
    Bohunickå E; Koza I; Ujhåzy V
    Neoplasma; 1974; 21(6):659-63. PubMed ID: 4479976
    [No Abstract]   [Full Text] [Related]  

  • 17. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
    Schmid FA; Hutchison DJ
    Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematologic and cytogenetic effects of androgens in cytostatic-treated mice (the micronucleus test).
    Ioan D
    Endocrinologie; 1981; 19(3):179-81. PubMed ID: 6794141
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement of cytogenetic damage and of antineoplastic effect in lymphoid L1210 leukemia cells treated with prostaglandin E2 and cyclophosphamide in vivo.
    Mourelatos D; Mioglou E; Kristi Z; Dozi-Vassiliades J
    Mutat Res; 1995 Jan; 326(1):125-9. PubMed ID: 7528880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of an extract from regenerating splenic tissue inhibiting DNA synthesis predominantly in leukemic cells].
    Svirnovskiĭ AI; Shimanskaia TV; Ageĭchik VM; Bakun AV; Levin VI
    Gematol Transfuziol; 1983 Apr; 28(4):24-8. PubMed ID: 6852509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.